Grunberg Gregory
Insider CIK 1711080 · KALA Director, 10% owner · ETNB Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ETNB 89bio, Inc. | A Award deriv | 2023-02-09 | 2023-02-13 | 27,400 | — | $0 | 27,400 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2022-05-16 | 2022-05-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2021-06-17 | 2021-06-21 | 20,000 | — | $0 | 40,000 | SEC↗ |
| ETNB 89bio, Inc. | S Sale | 2021-04-21 | 2021-04-23 | 850 | $27.60 | $23.5K | 0 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2021-04-15 | 2021-04-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ETNB 89bio, Inc. | J Other | 2020-11-16 | 2020-11-18 | 850 | — | $0 | 850 | SEC↗ |
| ETNB 89bio, Inc. | J Other | 2020-11-16 | 2020-11-18 | 850,000 | — | $0 | 1,750,877 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2020-07-10 | 2020-07-14 | 109,090 | $27.50 | $3.00M | 2,600,877 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award | 2020-06-25 | 2020-06-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2020-06-22 | 2020-07-14 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2020-04-05 | 2020-04-07 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | P Buy | 2020-03-13 | 2020-03-16 | 2,534,854 | $7.89 | $20.00M | 2,534,854 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 11,916,667 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 1,916,787 | — | $0 | 2,491,787 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2019-11-11 | 2019-11-13 | 575,000 | $16.00 | $9.20M | 575,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2019-06-05 | 2019-06-07 | 21,000 | — | $0 | 21,000 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | P Buy | 2018-10-05 | 2018-10-09 | 606,060 | $8.25 | $5.00M | 2,877,006 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2018-06-12 | 2018-06-14 | 12,960 | — | $0 | 12,960 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion deriv | 2017-07-25 | 2017-07-26 | 10,707,985 | — | $0 | 0 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | P Buy | 2017-07-25 | 2017-07-26 | 215,000 | $15.00 | $3.23M | 2,270,946 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | C Conversion | 2017-07-25 | 2017-07-26 | 2,055,946 | — | $0 | 2,055,946 | SEC↗ |
| KALA Kala Pharmaceuticals, Inc. | A Award deriv | 2017-07-19 | 2017-07-21 | 12,960 | — | $0 | 12,960 | SEC↗ |